The spread of coronavirus, known since December 2019, goes onto become one of deadly disease all around the world. Governments within their respective country are trying hard to keep the spread under control while encouraging front line workers and healthcare personnel are helping patients to cope up with the situation. Amongst all of this, the response by In Vitro Diagnosis (IVDs) has accelerated the hope for an optimized procedure against the speedy detection of SARS Cov-2 on a mass scale.
In Vitro Diagnostics in Brief:
When COVID-19 emerged in the early of 2020 hitting every other country in its way, human testing began massively and countries adopted to a unique but relentless clinical methodology. There was no way but antigen and swab tests to understand the severity of the infection in patients. Thus, In Vitro Diagnosis became predominant and a widely adopted clinical methodology all over the world. Using an IVD device, tests are performed on samples acquired from human body such as mucus, throat swab or blood taken from vein. IVDs are highly capable of detection and monitoring medical condition of a person to understand any anomaly and provide the line of treatment in less time.
USFDA and CDC categorized the type of IVDs for SARS CoV-2 and COVID-19 wherein Serology, Adaptive Immune Response Tests, and Antibody, measures the immune response to the SARS CoV-2. However, these tests are not used in the detection of infection. For detecting the infection, diagnostic tests such as antigen and swab tests are preferred to correctly identify the stage of infection, a person is going through.
From this, it is clearly evident that the pandemic has stimulated the IVDs as a mainstream clinical procedure for understanding upon the biological nature of virus followed by level of infection in patients. SARS CoV-2 has now spread to 200+ new countries since its inception and grows exponentially. Mainly, the elderly population with age of 65+ are known as early victims.
Why In Vitro Diagnostics have become Important?
The importance for In Vitro Diagnostics has grown to a higher extent through the pandemic situation thereby speeding up lab tests and point-of-care (POC) diagnosis is acquired in the mean time. Ongoing research and scientific data remains supportive of IVDs and working round the clock to enable commercially available diagnostic tests. Till date, 30 commercially available COVID-19 IVDs have received EUA (Emergency Use Authorization) from FDA. These are further used by laboratories, testing clinics and hospitals to diagnose symptomatic patients in the U.S.
Related Press [email protected] https://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-market
The Impact of COVID-19:
There can be many supporting facts in favour of IVDs for COVID-19 and with the high adoption new opportunities can be sought of. Again, there is much to cover beyond the scope, we have just pinpointed the known facts here.
Read More @ https://gvrencompass.wordpress.com/2021/05/07/covid-19-impact-on-in-vitro-diagnostics
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
For More Information: https://www.grandviewresearch.com